NSCLC tumors; adjacent normal tissues; LUAD tissues; LUSC tissues
-
not specified
RNA-seq; Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; RT-qPCR; RNase R Treatment; Clinical Sample Validation; ROC Analysis
ROC curve analysis supports diagnostic potential to discriminate NSCLC from normal tissues (AUC 0.863).
hsa_circ_0001821 (circPVT1) is up-regulated in both LUAD and LUSC tumor tissues compared with adjacent normal tissues. It has diagnostic potential for NSCLC by ROC analysis and is suggested to potentially promote NSCLC progression.
0.6605
RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma.
combined biological and clinical study